SYBLEU INC (SYBE)
USD 0.06
(34.15%)
USD 0.06
(34.15%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 473.71 Thousand USD | 547.59% |
| 2021 | 73.15 Thousand USD | 1460.17% |
| 2020 | -5378.00 USD | -185.65% |
| 2019 | 6279.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | 482.86 Thousand USD | 1.93% |
| 2023 Q2 | 473.71 Thousand USD | 244.24% |
| 2023 Q1 | 137.61 Thousand USD | 33.41% |
| 2023 Q4 | 488.32 Thousand USD | 1.13% |
| 2022 Q4 | 103.15 Thousand USD | 19.77% |
| 2022 Q3 | 86.12 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 42.79 Million USD | 98.893% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 23.885% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 289.774% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 2421.217% |
| Qrons Inc. | 351.42 Thousand USD | -34.797% |
| Rebus Holdings, Inc. | 305 Thousand USD | -55.316% |
| Skye Bioscience, Inc. | -5.72 Million USD | 108.28% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 107.514% |
| Adynxx, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 98.909% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -2284.426% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 91.613% |
| Burzynski Research Institute, Inc. | -1310.00 USD | 36261.374% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 96.995% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 88.497% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -17.884% |
| SQZ Biotechnologies Company | -36.23 Million USD | 101.307% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 78.873% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 48.908% |
| Mesoblast Limited | 55.85 Million USD | 99.152% |
| Marizyme, Inc. | 18.56 Million USD | 97.449% |
| Genus plc | 190.6 Million USD | 99.751% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 78.813% |
| Pharming Group N.V. | 109.8 Million USD | 99.569% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 44.932% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 60.975% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 30.336% |
| ContraFect Corporation | -6.02 Million USD | 107.861% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -251.84% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 59.001% |
| IMV Inc. | 7.67 Million USD | 93.824% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 91.39% |
| MultiCell Technologies, Inc. | 90.04 USD | -526015.06% |
| ONE Bio Corp. | 9.04 Million USD | 94.76% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 164.541% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 96.341% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | 65.371% |
| Q BioMed Inc. | 4.06 Million USD | 88.332% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 98.45% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 52.991% |
| Biomind Labs Inc. | 711.4 Thousand USD | 33.411% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 99.218% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 76.307% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 96.301% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -31.693% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -238.842% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 78.487% |
| GB Sciences, Inc. | 1.74 Million USD | 72.889% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 357.75% |
| HST Global, Inc. | 96.79 Thousand USD | -389.409% |
| CSL Limited | 10.52 Billion USD | 99.995% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -129.716% |
| Halberd Corporation | 144.72 Thousand USD | -227.329% |
| Enzolytics Inc. | 981.65 Thousand USD | 51.743% |
| Agentix Corp. | 37.63 Thousand USD | -1158.84% |
| Resverlogix Corp. | 6.45 Million USD | 92.657% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 170.379% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 100.023% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 101.008% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 93.301% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 82.511% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 105.359% |
| AVAX Technologies, Inc. | -5.9 Million USD | 108.025% |
| Zenith Capital Corp. | 10.06 Thousand USD | -4607.015% |
| Genscript Biotech Corporation | -1.06 Billion USD | 100.045% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -136.346% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 80.146% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -187.956% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 2686.057% |
| Kadimastem Ltd | -253.1 Thousand USD | 287.163% |
| Helix BioMedix, Inc. | -2.57 Million USD | 118.432% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 97.664% |
| BioStem Technologies, Inc. | 4.47 Million USD | 89.407% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -135.381% |
| LadRx Corporation | -2.03 Million USD | 123.262% |
| Cell Source, Inc. | 9.23 Million USD | 94.869% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 25.419% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 25.419% |
| NovAccess Global Inc. | 2.17 Million USD | 78.255% |
| Affymax, Inc. | -5.59 Million USD | 108.464% |
| Itoco Inc. | 228.3 Thousand USD | -107.492% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -248.347% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 90.444% |
| Mobile Lads Corp. | 484.23 Thousand USD | 2.172% |
| CytoDyn Inc. | 20.26 Million USD | 97.662% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 73317.002% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 5211.099% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 93.853% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 89.372% |
| International Stem Cell Corporation | 2.59 Million USD | 81.71% |
| Bioxytran, Inc. | 1.89 Million USD | 75.053% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -658.999% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 78.279% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 86.205% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 94.461% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 38.686% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 137.897% |
| Neutra Corp. | 52.18 Thousand USD | -807.724% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 119.032% |
| PureTech Health plc | -167.19 Million USD | 100.283% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 293.425% |
| IXICO plc | -4.44 Million USD | 110.658% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 96.416% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 99.136% |
| CSL Limited | 10.52 Billion USD | 99.995% |
| Cellectis S.A. | -43.81 Million USD | 101.081% |